
1. General Information
TEMOTERO 20 mg Capsules are an oral chemotherapy medicine containing Temozolomide 20 mg. Temozolomide belongs to the alkylating-agent class of anticancer medicines. It is prescribed by oncology specialists according to the patient's diagnosis, treatment stage, blood counts, and other clinical factors.
Phoenix Exim can describe TEMOTERO 20 mg Capsules as part of its pharmaceutical export portfolio from Nagpur, India, with intended markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable prescription, import, and regulatory requirements in each destination.
2. Product Information
- Brand: TEMOTERO 20
- Active ingredient: Temozolomide
- Strength: 20 mg
- Dosage form: Hard gelatin capsule
- Therapeutic class: Antineoplastic / alkylating agent
- Route: Oral
- Manufacturer/Marketer: Hetero Healthcare / Hetero Drugs
- Prescription status: Prescription medicine
- Storage: Generally store below 30°C and protect according to the product label.
3. Uses of TEMOTERO 20 mg
Temozolomide is used for specific malignant brain tumours. Depending on the patient's condition, it may be prescribed for:
- Newly diagnosed glioblastoma multiforme, generally alongside radiotherapy followed by maintenance treatment.
- Recurrent or progressive malignant gliomas, including glioblastoma multiforme and anaplastic astrocytoma, following standard treatment.
- Other uses only when specifically determined appropriate by an oncology specialist.
4. Benefits of This Medicine
The potential therapeutic benefits of Temozolomide include:
- Helps slow or inhibit the growth of certain brain tumour cells.
- Can be incorporated into treatment protocols for glioblastoma and other malignant gliomas.
- May be used with radiotherapy during certain treatment phases.
- Provides an oral chemotherapy option, allowing administration according to the prescribed treatment schedule.
The actual response varies considerably between patients, and the medicine should be used only according to an oncologist's treatment plan.
5. Side Effects
Because Temozolomide is a chemotherapy medicine, it can affect both cancerous and healthy rapidly dividing cells. Possible adverse effects include:
- Nausea and vomiting
- Fatigue or weakness
- Headache
- Constipation
- Loss of appetite
- Reduced blood-cell counts
- Increased susceptibility to infections
- Bruising or bleeding associated with low platelet counts
- Skin rash
Some reactions can be serious, particularly significant reductions in blood-cell counts or signs of infection, and require prompt medical attention.
6. Common Side Effects
Commonly reported effects include:
- Nausea
- Vomiting
- Fatigue
- Headache
- Constipation
- Loss of appetite
- Weakness
Doctors may prescribe supportive treatment, such as anti-nausea medication, when appropriate. Regular blood testing is important during treatment because Temozolomide can reduce blood-cell counts.
7. How to Use
TEMOTERO 20 mg should be taken only in the dose and schedule prescribed by the oncologist. The treatment schedule can vary depending on the cancer type and whether the medicine is being used with radiotherapy or as maintenance/recurrent-disease treatment.
- Take the capsule exactly as prescribed.
- Swallow the capsule whole with water.
- Do not crush, chew, or open the capsule unless specifically instructed by a healthcare professional.
- It is commonly administered on an empty stomach to help reduce nausea, but follow the exact instructions provided by the treating physician and product information.
- Do not change the dose or stop treatment without medical advice.
8. How TEMOTERO 20 mg Works
Temozolomide is an alkylating agent. After administration, it forms an active compound that can damage the DNA of rapidly dividing tumour cells. This DNA damage interferes with the cells' ability to replicate and divide, helping to inhibit tumour-cell growth.
9. Safety Advice
- Prescription only: Use under the supervision of an experienced oncology specialist.
- Blood tests: Regular monitoring of blood counts is important because the medicine can cause myelosuppression.
- Pregnancy: Temozolomide can harm an unborn baby. Discuss effective contraception and pregnancy planning with the treating doctor.
- Breastfeeding: Breastfeeding should generally be avoided during treatment because of the potential risk to the infant.
- Liver/kidney problems: Tell the doctor about existing liver or kidney problems before treatment.
- Infection: Report fever, chills, or other signs of infection promptly.
- Bleeding: Report unusual bruising or bleeding.
- Allergies: Do not use it if you have had a serious allergic reaction to Temozolomide or an appropriate related medicine.
- Drug interactions: Inform the oncologist about all prescription medicines, OTC medicines, and supplements being used.
- Driving: Fatigue or other treatment-related effects may affect alertness; drive only when medically appropriate.
10. FAQs
Q1. What is TEMOTERO 20 mg used for?
It contains Temozolomide and is used for specific malignant brain tumours, including glioblastoma and certain malignant gliomas.
Q2. Is TEMOTERO 20 mg a chemotherapy medicine?
Yes. Temozolomide is an oral anticancer chemotherapy medicine belonging to the alkylating-agent class.
Q3. Can I take TEMOTERO 20 mg without a prescription?
No. It should be used only under the direction of a qualified oncology specialist.
Q4. Should the capsule be opened or crushed?
The capsule should generally be swallowed whole. Follow the product instructions and your healthcare professional's advice.
Q5. Does TEMOTERO cause nausea?
Yes. Nausea and vomiting are among the commonly reported adverse effects, and doctors may provide antiemetic treatment when appropriate.
Q6. Why are blood tests needed during treatment?
Temozolomide can decrease white blood cells, neutrophils, lymphocytes, and platelets, so blood counts need monitoring.
Q7. Can TEMOTERO be used during pregnancy?
It should not be used during pregnancy unless specifically determined necessary by the treating specialist. Discuss contraception and pregnancy planning with your doctor.
Q8. Can I stop TEMOTERO when I feel better?
No. Cancer treatment schedules should not be changed or discontinued without the oncologist's instruction.
11. Substitutes for TEMOTERO 20 mg
Medicines containing the same active ingredient and strength may be considered alternatives, but a substitute should be selected by a doctor or pharmacist, not changed independently. Examples listed by Indian medicine references include:
- Temolon 20 mg Capsule
- Temoget 20 Capsule
- Nublast 20 mg Capsule
- Glioz 20 mg Capsule
- TEMOZAM 20 mg Capsule
Availability, manufacturer, formulation, and regulatory status can differ by country.
12. SEO / Product Keywords
- TEMOTERO 20 mg Capsules exporter from India
- TEMOTERO 20 mg Capsules supplier India
- Temozolomide 20 mg Capsules exporter
- Temozolomide 20 mg medicine supplier
- TEMOTERO 20 mg pharmaceutical exporter
- TEMOTERO 20 mg Capsules from Nagpur India
- Temozolomide Capsules wholesale supplier India
- TEMOTERO 20 mg oncology medicine exporter
- Temozolomide 20 mg brain tumour medicine
- TEMOTERO 20 mg cancer medicine supplier
- TEMOTERO 20 mg Capsules export to USA
- TEMOTERO 20 mg Capsules export to UK
- TEMOTERO 20 mg Capsules export to Australia
- TEMOTERO 20 mg Capsules export to Singapore
- TEMOTERO 20 mg Capsules export to Canada
- TEMOTERO 20 mg Capsules export to South Korea
- TEMOTERO 20 mg Capsules export to UAE
- Temozolomide 20 mg supplier for international markets
- Genuine TEMOTERO 20 mg Capsules supplier
- TEMOTERO 20 mg Hetero Healthcare supplier
- Temozolomide 20 mg oncology pharmaceutical supplier
- Brain cancer medicine exporter from India
- Anti-cancer medicine exporter Nagpur India
- Prescription oncology medicine exporter India
Keywords







